ABBV · News · 20261103N

Litigation and Legal Risk

AbbVie Inc. · 2026-11-03 · Importance 47 · Surprise 60

On November 3, 2026, AbbVie won a court case shielding Botox from Medicare price negotiations. The ruling concerns the U.S. Medicare drug-price negotiation program and prevents Botox from being subjected to those negotiations. The report does not identify the court, the legal basis for the ruling, or a quantified financial impact.

Key facts